225 related articles for article (PubMed ID: 33686665)
1. Thiotepa intrathecal injections for myelomatous central nervous system involvement.
Claudel A; Talbot A; Harel S; Royer B; Naelle L; Zagdanski AM; Madelaine I; Lemaire P; Arnulf B
Br J Haematol; 2021 Apr; 193(2):e9-e12. PubMed ID: 33686665
[No Abstract] [Full Text] [Related]
2. Intrathecal thiotepa: reappraisal of an established therapy.
Fisher PG; Kadan-Lottick NS; Korones DN
J Pediatr Hematol Oncol; 2002 May; 24(4):274-8. PubMed ID: 11972095
[TBL] [Abstract][Full Text] [Related]
3. Revisiting intrathecal thiotepa: Efficacy and safety in secondary CNS malignancies.
Jamison T; Haque E; Muhsen IN; Samarkandi H; Fakih RE; Aljurf M
Med Oncol; 2024 Jun; 41(7):177. PubMed ID: 38884819
[TBL] [Abstract][Full Text] [Related]
4. Intrathecal trastuzumab and thiotepa for leptomeningeal spread of breast cancer.
Ferrario C; Davidson A; Bouganim N; Aloyz R; Panasci LC
Ann Oncol; 2009 Apr; 20(4):792-5. PubMed ID: 19223574
[No Abstract] [Full Text] [Related]
5. Survival of breast cancer patients with meningeal carcinomatosis treated by intrathecal thiotepa.
Comte A; Jdid W; Guilhaume MN; Kriegel I; Piperno-Neumann S; Dieras V; Dorval T; Pierga JY; Cottu PH; Mignot L; Bidard FC
J Neurooncol; 2013 Dec; 115(3):445-52. PubMed ID: 24043602
[TBL] [Abstract][Full Text] [Related]
6. Meningeal myeloma in the absence of systemic disease, and as the initial feature of disease progression.
Somers LJ; Shaw B; Lyn BE; McMillan AM; Mahendra P
Clin Lab Haematol; 1998 Jun; 20(3):189-90. PubMed ID: 9681237
[TBL] [Abstract][Full Text] [Related]
7. Refractory plasmablastic type myeloma with multiple extramedullary plasmacytomas and massive myelomatous effusion: remarkable response with a combination of thalidomide and dexamethasone.
Nakazato T; Suzuki K; Mihara A; Sanada Y; Kakimoto T
Intern Med; 2009; 48(20):1827-32. PubMed ID: 19834276
[TBL] [Abstract][Full Text] [Related]
8. Comparison of high-dose melphalan with a more intensive regimen of thiotepa, busulfan, and cyclophosphamide for patients with multiple myeloma.
Anagnostopoulos A; Aleman A; Ayers G; Donato M; Champlin R; Weber D; Alexanian R; Giralt S
Cancer; 2004 Jun; 100(12):2607-12. PubMed ID: 15197803
[TBL] [Abstract][Full Text] [Related]
9. Salvage intracerebrospinal fluid thiotepa in breast cancer-related leptomeningeal metastases: a retrospective case series.
Le Rhun E; Taillibert S; Devos P; Zairi F; Turpin A; Rodrigues I; Cazin JL; Pierret MF; André C; Dubois F; Bonneterre J; Chamberlain MC
Anticancer Drugs; 2013 Nov; 24(10):1093-7. PubMed ID: 23962903
[TBL] [Abstract][Full Text] [Related]
10. Management of leptomeningeal malignancy.
Pentheroudakis G; Pavlidis N
Expert Opin Pharmacother; 2005 Jun; 6(7):1115-25. PubMed ID: 15957966
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment with pomalidomide and intrathecal injections for central nervous system plasmacytoma in a patient under haemodialysis.
Oka S; Ono K; Nohgawa M
J Clin Pharm Ther; 2020 Feb; 45(1):221-225. PubMed ID: 31602676
[TBL] [Abstract][Full Text] [Related]
12. Central nervous system involvement with multiple myeloma: long term survival can be achieved with radiation, intrathecal chemotherapy, and immunomodulatory agents.
Chen CI; Masih-Khan E; Jiang H; Rabea A; Cserti-Gazdewich C; Jimenez-Zepeda VH; Chu CM; Kukreti V; Trudel S; Tiedemann R; Tsang R; Reece DE
Br J Haematol; 2013 Aug; 162(4):483-8. PubMed ID: 23772701
[TBL] [Abstract][Full Text] [Related]
13. Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group.
Grossman SA; Finkelstein DM; Ruckdeschel JC; Trump DL; Moynihan T; Ettinger DS
J Clin Oncol; 1993 Mar; 11(3):561-9. PubMed ID: 8445432
[TBL] [Abstract][Full Text] [Related]
14. Meningeal and cerebral involvement in multiple myeloma patients.
Patriarca F; Zaja F; Silvestri F; Sperotto A; Scalise A; Gigli G; Fanin R
Ann Hematol; 2001 Dec; 80(12):758-62. PubMed ID: 11797120
[TBL] [Abstract][Full Text] [Related]
15. Salvage Treatment with Intracerebrospinal Fluid Thiotepa in Patients with Leptomeningeal Metastasis After Failure of Methotrexate-based Treatment.
Cho KM; Kim YJ; Kim SH; Kim JW; Lee JO; Han JH; Lee KW; Kim JH; Kim CY; Bang SM; Kim IA; Kim JS; Lee JS
Anticancer Res; 2015 Oct; 35(10):5631-8. PubMed ID: 26408736
[TBL] [Abstract][Full Text] [Related]
16. Evolution of hepatosplenic plasmacytoma in a patient with multiple myeloma receiving chemotherapy.
Malhotra P; Bhat P; Mahi S; Chauhan S; Rajwanshi A; Varma S
Am J Hematol; 2005 Jan; 78(1):82-3. PubMed ID: 15609282
[No Abstract] [Full Text] [Related]
17. [Thiotepa in the treatment of central nervous system leukemia in children].
Ochocka M; Barancewicz M; Ciepielewska D
Acta Haematol Pol; 1978; 9(4):263-7. PubMed ID: 104521
[TBL] [Abstract][Full Text] [Related]
18. [A case of meningeal myeloma associated with consciousness disorder].
Banba H; Shimizu T; Nakajima T; Mochizuki T
Nihon Naika Gakkai Zasshi; 1992 May; 81(5):726-7. PubMed ID: 1512503
[No Abstract] [Full Text] [Related]
19. [High-dose thiotepa chemotherapy in children].
Izhogin DG; Boiarshinov VK; Dolgonolov IS; Iankelevich MIa; Ptushkina EA; Mentkevich GL
Vopr Onkol; 2000; 46(4):401-6. PubMed ID: 11147412
[TBL] [Abstract][Full Text] [Related]
20. Treatment of malignant meningeal disease with intrathecal thioTEPA: a phase II study.
Gutin PH; Levi JA; Wiernik PH; Walker MD
Cancer Treat Rep; 1977 Aug; 61(5):885-7. PubMed ID: 408003
[No Abstract] [Full Text] [Related]
[Next] [New Search]
